The “classic” endocannabinoid (eCB) system includes the cannabinoid receptors CB1 and CB2, the eCB ligands anandamide (AEA) and 2-arachidonoylglycerol (2-AG), and their metabolic enzymes. An emerging literature documents the “eCB deficiency syndrome” as an etiology in migraine, fibromyalgia, irritable bowel syndrome, psychological disorders, and other conditions. We performed a systematic review of clinical interventions that enhance the eCB system—ways to upregulate cannabinoid receptors, increase ligand synthesis, or inhibit ligand degradation.
We searched PubMed for clinical trials, observational studies, and preclinical research. Data synthesis was qualitative. Exclusion criteria limited the results to 184 in vitro studies, 102 in vivo animal studies, and 36 human studies. Evidence indicates that several classes of pharmaceuticals upregulate the eCB system, including analgesics (acetaminophen, non-steroidal anti-inflammatory drugs, opioids, glucocorticoids), antidepressants, antipsychotics, anxiolytics, and anticonvulsants. Clinical interventions characterized as “complementary and alternative medicine” also upregulate the eCB system: massage and manipulation, acupuncture, dietary supplements, and herbal medicines. Lifestyle modification (diet, weight control, exercise, and the use of psychoactive substances—alcohol, tobacco, coffee, cannabis) also modulate the eCB system.
Few clinical trials have assessed interventions that upregulate the eCB system. Many preclinical studies point to other potential approaches; human trials are needed to explore these promising interventions.Read full article
This piece was reprinted by Project CBD. It may not be reproduced in any form without approval from the source.
A pioneer neurologist, Dr. Ethan Russo, examines recent scientific data on migraine, fibromyalgia, irritable bowel, and other treatment-resistant syndromes that may respond to cannabinoid therapies.
New research gives us food for thought on how the endocannabinoid system could be vital in understanding diet, digestion, and energy metabolism. It could be the key in understanding today’s obesity epidemic. What dietary changes can we make to support our endocannabinoid systems?
Professor Greg Gerdeman on brain science, the neurobiology of stress, and how science has liberated cannabis from the drug abuse paradigm.
Research on marijuana’s effects led directly to the discovery of a hitherto unknown biochemical communication system in the human body, the endocannabinoid system, which plays a crucial role in regulating our physiology, mood, and everyday experience.